FDA Inspection 1179659 — Athenex Pharma Solutions, LLC

Athenex Pharma Solutions, LLC — FEI 3008876196

The FDA completed an inspection of Athenex Pharma Solutions, LLC on Sep 16, 2022 in Clarence, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 16, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clarence, NY (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures